About: Adaptation of Contingency Management for Stimulant Use Disorder During the COVID-19 Pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Adaptation of Contingency Management for Stimulant Use Disorder During the COVID-19 Pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Adaptation of Contingency Management for Stimulant Use Disorder During the COVID-19 Pandemic
Creator	Sun, J Clune, J Zastepa, E
Source	Elsevier; Medline; PMC
abstract	Abstract The current coronavirus disease (COVID-19) pandemic has rapidly spread across the world. Individuals with stimulant use disorder are a vulnerable population, who are particularly at risk of negative outcomes during this pandemic due to several risk factors, including mental and physical comorbidities, weakened immune responses, high-risk behaviors, and barriers to healthcare access. Engaging patients with stimulant use disorder in regular treatment has become even more difficult during this pandemic, which has resulted in many cuts to addiction treatment programs. The most effective treatment options for stimulant use disorder are psychosocial interventions, which rely heavily on in-person interactions, which poses an added challenge during physical distancing. In particular, contingency management (CM) is a behavioral therapy that utilizes tangible reinforcements to incentivize targeted behavior changes, and is an effective treatment intervention used for stimulant use disorder. This paper highlights the treatment challenges for individuals with stimulant use disorder and the importance of adapting CM programs during COVID-19. We present strategies for how CM can be adapted and its role expanded in a safe way during the COVID-19 pandemic to help prevent infection spread, stimulant use relapse, and worsened psychosocial consequences.
has issue date	2020-08-11(xsd:dateTime)
bibo:doi	10.1016/j.jsat.2020.108102
bibo:pmid	32854983
has license	els-covid
sha1sum (hex)	42279f03a2b608a6291e713834513f3c7153c3aa
schema:url	https://doi.org/10.1016/j.jsat.2020.108102
resource representing a document's title	Adaptation of Contingency Management for Stimulant Use Disorder During the COVID-19 Pandemic
has PubMed Central identifier	PMC7417964
has PubMed identifier	32854983
schema:publication	J Subst Abuse Treat
resource representing a document's body	covid:42279f03a2b608a6291e713834513f3c7153c3aa#body_text
is schema:about of	named entity 'interactions' named entity 'options' named entity 'physical' named entity 'adapting' named entity 'Pandemic' named entity 'During' named entity 'COVID-19' named entity 'behavioral therapy' named entity 'contingency management' named entity 'pandemic' named entity 'disorder' named entity 'pandemic' named entity 'stimulant' named entity 'high-risk' named entity 'Government of British Columbia' named entity 'pharmacological' named entity 'urine' named entity 'New York Times' named entity 'AWOLs' named entity 'comorbidity' named entity 'COVID-19' named entity 'hand hygiene' named entity 'drug relapse' named entity 'psychological distress' named entity 'cocaine' named entity 'amphetamines' named entity 'hand hygiene' named entity 'mental illness' named entity 'Dantona' named entity 'effective' named entity 'highlights' named entity 'negative' named entity 'disorder' named entity 'infection' named entity 'coronavirus' named entity 'disorder' named entity 'Disorder' named entity 'contingency management' named entity 'stimulant' named entity 'infection' named entity 'addiction treatment programs' named entity 'treatment options' named entity 'Stimulant' named entity 'consequences' named entity 'risk factor' named entity 'COVID-19' named entity 'comorbidities' named entity 'healthcare access' named entity 'mental illness' named entity 'Rash' named entity 'operant conditioning' named entity 'COVID-19 pandemic' named entity 'staff member' named entity 'substance use disorders' named entity 'Stimulant' named entity 'mental health' named entity 'group setting' named entity 'not-for-profit' named entity 'COVID-19 pandemic' named entity 'stimulant' named entity 'stimulant' named entity 'relapse' named entity 'negative effects' named entity 'Rash' named entity 'stimulant' named entity 'COVID-19' named entity 'lung tissue' named entity 'immune responses' named entity 'stimulant' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'infection control' named entity 'infection' named entity 'personal protective equipment' named entity 'physical distancing' named entity 'physical distancing' named entity 'inflammation' named entity 'Social isolation' named entity 'treatment services'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software